Actively Recruiting
Study of Risk Factors for Mesh-Related Infection Following Abdominal Wall Reconstruction Surgery A Prospective Observational Cohort at a Tertiary Hernia Unit
Led by Minia University · Updated on 2026-08-18
420
Participants Needed
1
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
This research investigates risk factors for mesh-related infections following abdominal wall reconstruction AWR, a procedure used to repair ventral, incisional, parastomal, and complex abdominal wall defects. Mesh infections can lead to serious complications like prolonged hospitalization, additional surgeries, or mesh removal. The study is a prospective, single-center observational cohort conducted at a tertiary hernia surgery unit, enrolling adults undergoing AWR with various types of mesh. Participants undergo routine surgical and perioperative care without specific interventions imposed by the study. They receive synthetic, biosynthetic, or biological mesh during elective or urgent AWR. The study spans 24 months 12 months of consecutive enrollment followed by 12 months of follow-up per participant. No treatment assignments are made, as exposures are observed based on standard practice. Participants are followed on a fixed schedule at baseline, 7-10 days, 30 days, 90 days, 6 months, and 12 months after surgery. Researchers collect detailed data on patient, defect, operative, and perioperative factors, using standardized definitions to confirm mesh infections within 90 days. Secondary outcomes include infection incidence over 12 months, microbiology, management approaches, surgical site complications, hernia recurrence, and reoperation rates. The study aims to improve risk assessment and decision-making for future patients.
CONDITIONS
Brief Title
Risk Factors for Mesh Infection After Abdominal Wall Reconstruction
Research Team
S
Saleh K Saleh, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here